ATP13A2 levels in serum and cerebrospinal fluid in patients with idiopathic Parkinson's disease.
The enzyme ATP13A2 holds promise as biomarker in Parkinson's disease (PD). No study has examined the content of ATP13A2 in serum and cerebrospinal fluid (CSF) in idiopathic PD cohorts, or ho...